Improving recombinant MVA immune responses: Potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma

Virus Research

Volumn 116, Issue 1-2, 2006, Pages 11-20

  Abaitua, Fernando ^a,b   Rodríguez, Juan Ramón ^c   Garzón, Ana ^a   Rodríguez, Dolores ^a   Esteban, Mariano ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b MARIE CURIE RESEARCH INSTITUTE   (United Kingdom)

^c Bionostra   (Spain)

Author keywords

CD8+ T cells; Enhancing immunogenicity; HIV vaccines; IL 12 and IFN gamma; MVA and DNA vectors

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; NAKED DNA; RECOMBINANT DNA; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA VECTOR; EMBRYO; FEMALE; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DNA, VIRAL; FEMALE; GENE PRODUCTS, ENV; GENETIC VECTORS; HIV-1; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; VACCINES, DNA; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL VACCINES;

ANIMALIA; ANKARA; HUMAN IMMUNODEFICIENCY VIRUS 1; VACCINIA VIRUS;

EID: 32344439457     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2005.08.008     Document Type: Article

References (46)

1. A.K. Abbas, K.M. Murphy, and A. Sher Functional diversity of helper T lymphocytes Nature 383 6603 1996 787 793 (review)
2. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, S.I. Staprans, D.C. Montefiori, Y. Xu, J.G. Herndon, L.S. Wyatt, M.A. Candido, N.L. Kozyr, P.L. Earl, J.M. Smith, H.L. Ma, B.D. Grimm, M.L. Hulsey, J. Miller, H.M. McClure, J.M. McNicholl, B. Moss, and H.L. Robinson Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 5514 2001 69 74
3. A. Billiau Interferon-gamma: biology and role in pathogenesis Adv. Immunol. 62 1996 61 130 (review)
4. T.J. Blanchard, A. Alcami, P. Andrea, and G.L. Smith Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine J. Gen. Virol. 79 1998 1159 1167
5. J.D. Boyer, A.D. Cohen, K.E. Ugen, R.L. Edgeworth, M. Bennett, A. Shah, K. Schumann, B. Nath, A. Javadian, M.L. Bagarazzi, J. Kim, and D.B. Weiner Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids AIDS 14 11 2000 1515 1522
6. L.M. Bradley, K. Yoshimoto, and S.L. Swain The cytokines IL-4, IFN-gamma, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro J. Immunol. 155 4 1995 1713 1724
7. M.W. Carroll, W.W. Overwijk, D.R. Surman, K. Tsung, B. Moss, and N.P. Restifo Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen J. Natl. Cancer Inst. 90 1998 1881 1887
8. Y.H. Chow, B.L. Chiang, Y.L. Lee, W.K. Chi, W.C. Lin, Y.T. Chen, and M.H. Tao Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes J. Immunol. 160 3 1998 1320 1329
9. M. Clerici, C. Balotta, L. Meroni, E. Ferrario, C. Riva, D. Trabattoni, A. Ridolfo, M. Villa, G.M. Shearer, M. Moroni, and M. Galli Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection AIDS Res. Hum. Retroviruses 12 11 1996 1053 1061
10. N.A. Doria-Rose, C. Ohlen, P. Polacino, C.C. Pierce, M.T. Hensel, L. Kuller, T. Mulvania, D. Anderson, P.D. Greenberg, S.L. Hu, and N.L. Haigwood Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge J. Virol. 77 21 2003 11563 11577
11. K. Fruh, and Y. Yang Antigen presentation by MHC class I and its regulation by interferon gamma Curr. Opin. Immunol. 11 1 1999 76 81 (review)
12. M.M. Gherardi, J.C. Ramirez, D. Rodriguez, J.R. Rodriguez, G. Sano, F. Zavala, and M. Esteban Il-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner J. Immunol. 162 1999 6724 6733
13. M.M. Gherardi, J.C. Ramirez, and M. Esteban Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide J. Virol. 74 14 2000 6278 6286
14. M.M. Gherardi, J.C. Ramirez, and M. Esteban Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens Histol. Histopathol. 16 2 2001 655 667 (review)
15. S. Guerra, L.A. Lopez-Fernandez, R. Conde, A. Pascual-Montano, K. Harshman, and M. Esteban Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells J. Virol. 78 2004 5820 5834
16. T. Hanke, T.J. Blanchard, J. Schneider, C.M. Hannan, M. Becker, S.C. Gilbert, A.V. Hill, G.L. Smith, and A. McMichael Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime Vaccine 16 1998 439 445
17. W.R. Joklik The preparation and characteristics of highly purified radioactively labelled poxvirus Biochem. Biophys. Acta 61 1962 290 301
18. Y. Kadota, M. Okumura, S. Miyoshi, S. Kitagawa-Sakakida, M. Inoue, H. Shiono, Y. Maeda, T. Kinoshita, R. Shirakura, and H. Matsuda Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma) Clin. Exp. Immunol. 121 1 2000 59 68
19. G. Karupiah, Q.W. Xie, R.M. Buller, C. Nathan, C. Duarte, and J.D. MacMicking Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase Science 261 5127 1993 1445 1448
20. S.J. Kent, A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J. Virol. 72 12 1998 10180 10188
21. S. Lee, M. Gierynska, S.K. Eo, N. Kuklin, and B.T. Rouse Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus Microbes Infect. 5 7 2003 571 578
22. J. Mackova, L. Kutinova, P. Hainz, J. Krystofova, V. Sroller, P. Otahal, P. Gabriel, and S. Nemeckova Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL-12 Int. J. Oncol. 24 2004 1581
23. A. Mayr, and E. Munz Changes in the vaccinia virus through continuing passages in chick embryo fibroblast cultures Zentralbl. Bakteriol. [Orig.] 195 1964 24 35
24. A. Mayr, and K. Danner Vaccination against pox diseases under immunosuppressive conditions Dev. Biol. Stand. 41 1978 225 234
25. A. Mayr, H. Stickl, H.K. Muller, K. Danner, and H. Singer The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl) Zentralbl. Bakteriol. [b] 167 1978 375 390
26. S.J. McConkey, W.H. Reece, V.S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J.M. Vuola, T.J. Blanchard, P. Gothard, K. Watkins, C.M. Hannan, S. Everaere, K. Brown, K.E. Kester, J. Cummings, J. Williams, D.G. Heppner, A. Pathan, K. Flanagan, N. Arulanantham, M.T. Roberts, M. Roy, G.L. Smith, J. Schneider, T. Peto, R.E. Sinden, S.C. Gilbert, and A.V. Hill nhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Nat. Med. 9 6 2003 729 735
27. Y. Miyahira, K. Murata, D. Rodriguez, J.R. Rodriguez, M. Esteban, M.M. Rodrigues, and F. Zavala Quantification of antigen specific CD8+ T cells using an ELISPOT assay J. Immunol. Methods 181 1 1995 45 54
28. T.R. Mosmann, and S. Sad The expanding universe of T-cell subsets: Th1 Th2 and more Immunol. Today 17 3 1996 138 146 (review)
29. B. Moss, M.W. Carroll, L.S. Wyatt, J.R. Bennink, V.M. Hirsch, S. Goldstein, W.R. Elkins, T.R. Fuerst, J.D. Lifson, M. Piatak, N.P. Restifo, W. Overwijk, R. Chamberlain, S.A. Rosenberg, and G. Sutter Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates Adv. Exp. Med. Biol. 397 1996 7 13
30. S. Nemeckova, V. Sroller, P. Hainz, J. Krystofova, M. Smahel, and L. Kutinova Experimental therapy of HPV16 induced tumors with IL12 expressed by recombinant vaccinia virus in mice Int. J. Mol. Med. 12 5 2003 789 796
31. S. Nimal, A.L. McCormick, M.S. Thomas, and A.W. Heath An interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming Vaccine 10 23(30) 2005 3984 3990
32. A. O'Garra Commitment factors for T helper cells Curr. Biol. 10 13 2000 R492 R494
33. E. Paoletti Applications of poxvirus vectors to vaccination: an update Proc. Natl. Acad. Sci. U.S.A. 93 21 1996 11349 11353 (review)
34. T.M. Pertmer, A.E. Oran, C.A. Madorin, and H.L. Robinson Th1 genetic adjuvants modulate immune responses in neonates Vaccine 19 13-14 2001 1764 1771
35. J.C. Ramírez, M.M. Gherardi, and M. Esteban Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine J. Virol. 74 2 2000 923 933
36. J.C. Ramírez, M.M. Gherardi, D. Rodriguez, and M. Esteban Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector J. Virol. 74 2000 7651 7655
37. J.F. Rodriguez, D. Rodriguez, J.R. Rodriguez, E.B. McGowan, and M. Esteban Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals Proc. Natl. Acad. Sci. U.S.A. 85 1988 1667 1671
38. S. Santra, D.H. Barouch, B. Korioth-Schmitz, C.I. Lord, G.R. Krivulka, F. Yu, M.H. Beddall, D.A. Gorgone, M.A. Lifton, A. Miura, V. Philippon, K. Manson, P.D. Markham, J. Parrish, M.J. Kuroda, J.E. Schmitz, R.S. Gelman, J.W. Shiver, D.C. Montefiori, D. Panicali, and N.L. Letvin Recombiant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses Proc. Natl. Acad. Sci. U.S.A. 101 2004 11088 11093
39. M. Sedegah, T.R. Jones, M. Kaur, R. Hedstrom, P. Hobart, J.A. Tine, and S.L. Hoffman Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine Proc. Natl. Acad. Sci. U.S.A. 95 13 1998 7648 7653
40. C.M. Snapper, and J.J. Mond A model for induction of T cell-independent humoral immunity in response to polysaccharide antigen J. Immunol. 157 1996 2229 2233
41. G. Sutter, and B. Moss Nonreplicating vaccinia vector efficiently expresses recombinant genes Proc. Natl. Acad. Sci. U.S.A. 89 1992 10847 10851
42. G. Sutter, and C. Staib Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery Curr. Drug Targets Infect. Disord. 3 3 2003 263 271 (review)
43. S.L. Swain Generation and in vivo persistence of polarized Th1 and Th2 memory cells Immunity 1 7 1994 543 552
44. T. Woodberry, J. Gardner, S.L. Elliott, S. Leyrer, D.M. Purdie, P. Chaplin, and A. Suhrbier Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 bias J. Immunol. 170 5 2003 2599 2604
45. F. Zavala, M. Rodrigues, D. Rodriguez, J.R. Rodriguez, R.S. Nussenzweig, and M. Esteban A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8 (+) T cells Virology 280 2 2001 155 159 (review)
46. Y. Zhu, P. Rota, L. Wyatt, A. Tamin, S. Rozenblatt, N. Lerche, B. Moss, W. Bellini, and M. McChesney Evaluation of recombinant vaccinia virus-measles vaccines in infant rhesus macaques with preexisting measles antibody Virology 276 1 2000 202 213